SHORT BOWEL SYNDROME IN CHILDREN.

Area of Science:

• Gastroenterology and Hepatology
• Surgical Sciences

Background:

• Short bowel syndrome (SBS) is a severe complication following major intestinal resection, characterized by malabsorption and diarrhea.
• Recent advancements have improved patient outcomes through a deeper understanding of SBS and its associated complications.

Purpose of the Study:

• To review the current understanding and management strategies for short bowel syndrome.
• To highlight the evolving therapeutic landscape, including medical, nutritional, and surgical interventions.

Main Methods:

• Literature review of medical and surgical management of short bowel syndrome.
• Analysis of the impact of total parenteral nutrition and medical therapies on SBS outcomes.
• Evaluation of the role of intestinal transplantation in refractory cases.

Main Results:

• Medical therapies, including H2 receptor antagonists, loperamide, and growth hormone analogues, have demonstrated efficacy.
• Total parenteral nutrition (TPN) has significantly improved the management and outcomes of SBS.
• Surgical interventions aimed at slowing transit or lengthening the intestine have not gained widespread clinical acceptance.
• Intestinal transplantation is a key option for patients with inadequate intestinal adaptation or TPN-related complications.

Conclusions:

• Effective management of short bowel syndrome involves a multi-faceted approach.
• Medical therapies and TPN are cornerstones of current SBS treatment.
• Intestinal transplantation offers a life-saving option for complex and refractory cases of short bowel syndrome.